4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Precision BioSciences, Inc. (DTIL) operates in the Biotechnology industry and is headquartered in Durham, United States with about 66 employees. Its market capitalization is roughly $227 million. In the fiscal year ended 2025-12-31, DTIL reported $34M in revenue and ($46M) in net income.
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States. The company offers ARCUS, a genome editing platform for DNA genome insertion, removal, and repair.
Interactive charts & full statements → Open the DTIL valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $34M | $69M | $49M | $25M | — |
| Operating Income (EBIT) | ($52M) | ($26M) | ($44M) | ($62M) | — |
| Net Income | ($46M) | $7M | ($61M) | ($112M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $11M | $34M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($9M) | $12M | ($21M) | ($22M) | ($22M) | — |
| Net Income | ($18M) | $20M | ($22M) | ($24M) | ($21M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $154M | $136M | $160M | $238M | — |
| Total Liabilities | $62M | $80M | $141M | $178M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive DTIL viewer.
About TickerBase · Data methodology & sources